Ignite Creation Date:
2024-05-06 @ 7:21 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02510092
Status:
COMPLETED
Last Update Posted:
2021-04-23
First Post:
2015-07-23
Brief Title:
Coronary Artery and Systemic Autoimmune Disease Diagnostics and Treatment
Sponsor:
Semmelweis University Heart and Vascular Center
Organization:
Semmelweis University Heart and Vascular Center
Study Overview
Official Title:
In Vivo Intravascular Diagnostics and Evaluation of New Therapeutic Modalities in Systemic Autoimmune and Coronary Artery Disease Patients
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates in vivo intracoronary imaging using intravascular ultrasound and optical coherence tomography and safety and efficacy of new generation fully bioresorbable vascular scaffolds in four well defined systemic autoimmune rheumatoid arthritis mixed connective tissue disease systemic sclerosis systemic lupus erythematosus and concomitant coronary disease patients
Detailed Description:
The aim of this study is to assess in vivo intracoronary anatomy using intravascular ultrasound and optical coherence tomography and assess the efficacy and safety of new generation fully bioresorbable vascular scaffolds in a systemic autoimmune and coronary heart disease patient population
The following four well defined systemic autoimmune entities are linked to increased cardiovascular risk rheumatoid arthritis mixed connective tissue disease systemic sclerosis and systemic lupus erythematosus One of the main causes of death in systemic autoimmune subjects is cardiovascular disease In-vivo intracoronary anatomy and pathology regarding systemic autoimmune diseases is unknown Furthermore all forms of revascularization in such patients yield sub-optimal results with poor outcomes using even the most modern drug eluting metallic stents This may be linked to a long term exaggerated chronic inflammation response to the metallic components Thus fully bioresorbable vascular scaffolds may prove more efficacious in systemic autoimmune subjects
The following four well defined systemic autoimmune entities are linked to increased cardiovascular risk rheumatoid arthritis mixed connective tissue disease systemic sclerosis and systemic lupus erythematosus One of the main causes of death in systemic autoimmune subjects is cardiovascular disease In-vivo intracoronary anatomy and pathology regarding systemic autoimmune diseases is unknown Furthermore all forms of revascularization in such patients yield sub-optimal results with poor outcomes using even the most modern drug eluting metallic stents This may be linked to a long term exaggerated chronic inflammation response to the metallic components Thus fully bioresorbable vascular scaffolds may prove more efficacious in systemic autoimmune subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None